We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+4.7%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$54B
AUM Growth
-$5.26B
(-8.9%)
Cap. Flow
-$7.55B
Cap. Flow
% of AUM
-13.98%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
190
New
14
Increased
43
Reduced
46
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$849M |
| 2 |
Alibaba
BABA
|
+$551M |
| 3 |
dLocal
DLO
|
+$178M |
| 4 |
Baidu
BIDU
|
+$156M |
| 5 |
NetEase
NTES
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$311M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$246M |
| 3 |
Synopsys
SNPS
|
+$242M |
| 4 |
XLRN
Acceleron Pharma
XLRN
|
+$214M |
| 5 |
Twilio
TWLO
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Consumer Discretionary | 10.52% |
| 3 | Financials | 4.99% |
| 4 | Communication Services | 4.7% |
| 5 | Real Estate | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
101
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $61.9M | 0.11% |
1,909,035
-1,217,400
| -39% | -$43M |
|
102
Trip.com Group
TCOM
$29.1B
| $60.7M | 0.11% |
2,466,038
-4,030,542
| -62% | -$114M |
|
103
Pinduoduo
PDD
$131B
| $58.5M | 0.11% |
+1,003,470
| New | +$79.1M |
|
104
Marqeta
MQ
$1.66B
| $56.6M | 0.1% |
824,570
+312,500
| +61% | +$28M |
|
105
Keros Therapeutics
KROS
$221M
| $54.2M | 0.1% |
926,433
+225,000
| +32% | +$11.2M |
|
106
GitLab
GTLB
$6.58B
| $53.2M | 0.1% |
+611,206
| New | +$62.6M |
|
107
Full Truck Alliance
YMM
$9.99B
| $52.8M | 0.1% |
6,313,468
-3,253,144
| -34% | -$43M |
|
|
AKRO
108
DELISTED
Akero Therapeutics
AKRO
| $52.4M | 0.1% |
2,479,671
| – | – |
|
|
AZPN
109
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $51.7M | 0.1% |
340,000
-93,748
| -22% | -$14.3M |
|
110
Okta
OKTA
$25.8B
| $50.5M | 0.09% |
225,437
| – | – |
|
|
CTLT
111
DELISTED
CATALENT, INC.
CTLT
| $38.4M | 0.07% |
+300,000
| New | +$38.5M |
|
112
New Oriental
EDU
$8.98B
| $38.1M | 0.07% |
1,816,576
-577,699
| -24% | -$12.5M |
|
113
PMV Pharmaceuticals
PMVP
$63.5M
| $36.9M | 0.07% |
1,599,553
+180,000
| +13% | +$4.35M |
|
114
CALL
KraneShares CSI China Internet ETF
KWEB
$5.67B
| $36.5M | 0.07% |
+1,000,000
| New | +$46M |
|
115
TG Therapeutics
TGTX
$7.62B
| $35.5M | 0.07% |
1,868,301
-2,200,000
| -54% | -$57.1M |
|
|
ANSS
116
DELISTED
Ansys
ANSS
| $34.7M | 0.06% |
86,441
-221,600
| -72% | -$85.1M |
|
117
JFrog
FROG
$10.8B
| $33.8M | 0.06% |
1,137,998
-414,510
| -27% | -$13.7M |
|
118
Bilibili
BILI
$7.84B
| $29.4M | 0.05% |
633,450
-284,775
| -31% | -$19M |
|
|
IGMS
119
DELISTED
IGM Biosciences
IGMS
| $27.5M | 0.05% |
939,035
-9,762
| -1% | -$485K |
|
|
ALTR
120
DELISTED
Altair Engineering Inc
ALTR
| $23.4M | 0.04% |
302,004
-375,000
| -55% | -$28.1M |
|
121
ServiceNow
NOW
$129B
| $23M | 0.04% |
176,855
| – | – |
|
122
Oric Pharmaceuticals
ORIC
$1.4B
| $21M | 0.04% |
1,426,968
+429,979
| +43% | +$6.7M |
|
123
Schrodinger
SDGR
$1.36B
| $20.9M | 0.04% |
599,206
+250,000
| +72% | +$11.4M |
|
|
RNAM
124
DELISTED
Avidity Biosciences
RNAM
| $20.4M | 0.04% |
856,466
-14,960
| -2% | -$357K |
|
125
Xometry
XMTR
$5.34B
| $19.2M | 0.04% |
373,700
+198,700
| +114% | +$10.2M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Alkeon Capital Management held 190 positions worth $54B, down 8.9% from $59.2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Alkeon Capital Management withdrew a net $7.55B in Q4 2021, closing 38 positions and reducing 46 holdings. Its most notable exit was Netflix, an estimated $311M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Alkeon Capital Management opened a new position in Qualcomm worth $970M.
- Alkeon Capital Management's largest Q4 2021 buy was Qualcomm: 5,305,000 shares worth $970M.
- Alkeon Capital Management added most to Alibaba in Q4 2021, an estimated $551M increase.
- Alkeon Capital Management's biggest Q4 2021 reduction was Activision Blizzard, cutting an estimated $246M.
- Alkeon Capital Management fully exited Netflix in Q4 2021, selling an estimated $311M.
- Alkeon Capital Management's ten largest holdings make up 50% of its $54B portfolio in Q4 2021.
- Alkeon Capital Management opened 14 new positions and closed 38 in Q4 2021.
- Alkeon Capital Management's portfolio value fell 8.9% quarter-over-quarter to $54B.
Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.